High-Throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort

    Raiane P Crespo, Thaís Rocha, Luciana Ribeiro Montenegro, Mirian Yumie Nishi, Alexander A L Jorge, Gustavo Arantes Rosa Maciel, Edmund Chada Baracat, Ana Cláudia Latronico, Berenice B. Mendonca, Larissa Gomes
    Studysummary This study identified several rare genetic variants related to insulin resistance in women with PCOS, highlighting the potential for monogenic conditions in patients with extreme or atypical phenotypes.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study utilized high-throughput sequencing to identify rare genetic variants in a cohort of 53 women with polycystic ovary syndrome (PCOS). It found that 18.8% of the cases had rare genetic variants potentially linked to PCOS, including pathogenic and likely pathogenic variants in genes such as INSR, LMNA, PIK3R1, and DLK1. The findings suggest a genetic basis for PCOS in a subset of patients, particularly those with severe insulin resistance, and highlight the importance of genetic screening in understanding and managing the condition.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results